These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29587895)
21. Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia. Husain-Krautter S; Lee J; Vos D; Gallego JA; Malhotra AK; Rothstein TL Behav Brain Res; 2022 Mar; 422():113743. PubMed ID: 35007628 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis. Malter MP; Elger CE; Surges R Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046 [TBL] [Abstract][Full Text] [Related]
23. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy. Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care. Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625 [TBL] [Abstract][Full Text] [Related]
25. [Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach]. Steiner J; Prüß H; Köhler S; Hasan A; Falkai P Nervenarzt; 2018 May; 89(5):530-538. PubMed ID: 29523913 [TBL] [Abstract][Full Text] [Related]
26. Anti-neuronal anti-bodies in patients with early psychosis. Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116 [TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis. Rattay TW; Martin P; Vittore D; Hengel H; Cebi I; Tünnerhoff J; Stefanou MI; Hoffmann JF; von der Ehe K; Klaus J; Vonderschmitt J; Herrmann ML; Bombach P; Al Barazi H; Zeltner L; Richter J; Hesse K; Eckstein KN; Klingberg S; Wildgruber D Sci Rep; 2021 Mar; 11(1):7169. PubMed ID: 33785807 [TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. Bechter K; Reiber H; Herzog S; Fuchs D; Tumani H; Maxeiner HG J Psychiatr Res; 2010 Apr; 44(5):321-30. PubMed ID: 19796773 [TBL] [Abstract][Full Text] [Related]
30. Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects. Sørensen NV; Nilsson AC; Orlovska-Waast S; Jeppesen R; Christensen RHB; Benros ME Biol Psychiatry Glob Open Sci; 2023 Oct; 3(4):1116-1121. PubMed ID: 37881586 [TBL] [Abstract][Full Text] [Related]
31. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530 [TBL] [Abstract][Full Text] [Related]
32. High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders. Lütt A; Michel K; Krüger D; Volz MS; Nassir M; Schulz E; Poralla L; Tangermann P; Bojarski C; Höltje M; Teegen B; Stöcker W; Schemann M; Siegmund B; Prüss H Neurogastroenterol Motil; 2018 Jun; 30(6):e13292. PubMed ID: 29345029 [TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076 [TBL] [Abstract][Full Text] [Related]
34. No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia. van Mierlo HC; van Coevorden-Hameete MH; Munting LP; de Graaff E; de Witte L; Eur Neuropsychopharmacol; 2015 Dec; 25(12):2326-32. PubMed ID: 26482911 [TBL] [Abstract][Full Text] [Related]
35. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome. Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401 [TBL] [Abstract][Full Text] [Related]
36. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732 [TBL] [Abstract][Full Text] [Related]